PLUS THERAPEUTICS, INC. — Director's Dealing 2020

Feb 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2020-02-14

Reporting Person: Petersen Greg (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-14	Stock Option (right to buy)	$2.16	A	40000	Acquired	2030-02-14	Common Stock (40000)	Direct

Footnotes

F1: The options vest over two years as follows: 50% of the shares vest on February 14, 2021 and 1/24th of the shares vest each monthly anniversary thereafter.